about
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesPathophysiology of anorexia in the cancer cachexia syndromeSkeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise trainingMuscle wasting in animal models of severe illnessEnergy balance and metabolism after cancer treatmentSarcopenia in heart failure: mechanisms and therapeutic strategiesThe Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and AutoimmunityCancer cachexia: impact, mechanisms and emerging treatmentsLower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung CancerPharmacokinetics of drugs in cachectic patients: a systematic reviewReactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.Overfat and Underfat: New Terms and Definitions Long OverduePathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions.Locomotion and muscle mass measures in a murine model of collagen-induced arthritis.Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences.Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional studyBody composition among HIV-seropositive and HIV-seronegative adult patients with pulmonary tuberculosis in Uganda.A trial assessing N-3 as treatment for injury-induced cachexia (ATLANTIC trial): does a moderate dose fish oil intervention improve outcomes in older adults recovering from hip fracture?Update on clinical trials of growth factors and anabolic steroids in cachexia and wastingBody mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.Amplification and propagation of interleukin-1β signaling by murine brain endothelial and glial cells.Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer.Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review.One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA.Effects on muscle performance of NSAID treatment with piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. A double blind randomized controlled trial.Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle.Plasma and muscle myostatin in relation to type 2 diabetes.Cachexia as a major public health problem: frequent, costly, and deadly.The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits.Cachexia: a nutritional syndrome?Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.Ghrelin for cachexia.Neuropeptides in the pathophysiology and treatment of cachexia.Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatmentLaboratory aspects relating to the detection and prevention of frailtyResolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.Nutritional interventions for cancer-induced cachexia
P2860
Q26747940-D827CC81-C091-4611-BE5B-CC86E5A06933Q26767412-F0ECC541-F3E5-40EF-8A7F-56DFC1BC0F77Q26775294-047E0F5A-83CF-4DB7-98D6-1B3C0740B1F4Q26781640-83B499F9-A707-489D-8BA6-45A1F0971595Q27000450-93B5DAE4-D2DD-47F8-93ED-2E34E9A3A2C3Q27015118-1CDD87F8-75E8-45F8-8705-3648C9FCDF19Q28066237-4ADD4875-4E29-4CD0-9465-EAE3BB14C433Q28118489-F94C62D0-77ED-483E-A75F-033BEF797CDCQ28384479-AD43FA30-228C-4425-8264-93EF66A83151Q28394473-219919F3-11A3-4694-BAD5-D9B79EDA3288Q28535322-47B87B1E-C3D5-42FD-B1B6-806F03F448FBQ30275433-097EE1C1-B3F4-417E-9F31-B1884AACCE7DQ30397621-C1F8E574-6B79-4D65-89C9-40BFE84A089AQ30491371-C6DD84B2-8E7D-4A64-8ED5-39479E60CA01Q33459510-2C561DDA-A5D3-44B6-A479-F34BF8BEFF1DQ33614530-3D7BE1DF-D7EB-4770-AC3F-3802BF7CEB90Q33640519-C40AC6ED-2D2F-4FD4-9E1A-B5985729A637Q33669099-A2ECFD57-99C8-43CB-831D-B357998D4D86Q33724833-1A83E53F-0C5B-4CF8-92FF-D7F328505447Q33750201-B1D6276B-CCAF-4650-AA76-54EF7FC71BF1Q33813557-182C5CA7-17AF-4A5C-829E-1053659E8F7CQ33862561-26DBC5A2-6238-4A4F-AB32-9888210298A1Q33890809-DF4E50C5-B7BF-431B-9C72-EE876AF39F05Q33956866-5153B64A-8234-43C7-998A-887D4AD9D6F1Q34034275-055E573E-FDE3-41B4-8C15-441D0BC182C1Q34114652-2DB0095B-FC2C-4249-AC46-1DF4AA8B7D29Q34257035-EDA87CE4-CB74-4CE0-A6CF-0FEE9DBEDC29Q34277885-95FB96FA-7E8F-47FE-ACB5-F52C05116021Q34335859-2AF641F0-C453-4E3E-9DCB-8DD7BF52E3ECQ34369105-B9E2BB9D-BDF4-4CD1-AE7A-EAC290BB6798Q34389006-C0BD6685-493A-4BE3-8B08-D76D62E69FDEQ34505370-1079E5D5-24EA-42FB-90C9-EA0B20927E3DQ34591010-4CB968A2-1614-4CD6-8244-8E97F3E64364Q34697114-F3C6002F-AA13-40F3-BDF4-94AD84068226Q34697171-DBA1B2D7-0417-4C26-BAE0-0ED0DF162E1AQ34712204-0A6696C9-0792-4CA0-90A8-5DBB3750200AQ34768351-68936C53-894E-4857-9490-C128B1E3FB89Q34786601-38434988-FCBE-4B9B-AD2B-72402FCCD4D4Q34988904-9F149F2A-F5DC-4991-A219-A50F86DE7E9FQ35019743-D4443937-6055-41CB-B0AF-285CC0C318BD
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cachexia: pathophysiology and clinical relevance.
@ast
Cachexia: pathophysiology and clinical relevance.
@en
type
label
Cachexia: pathophysiology and clinical relevance.
@ast
Cachexia: pathophysiology and clinical relevance.
@en
prefLabel
Cachexia: pathophysiology and clinical relevance.
@ast
Cachexia: pathophysiology and clinical relevance.
@en
P2093
P356
P1476
Cachexia: pathophysiology and clinical relevance.
@en
P2093
David R Thomas
John E Morley
Margaret-Mary G Wilson
P304
P356
10.1093/AJCN/83.4.735
P407
P577
2006-04-01T00:00:00Z